Cove Private Wealth’s AbbVie ABBV Stock Holding History

Cove Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.11M	Buy	12,350 +155	+1%	+$33.3K	0.6%	32
2026 Q1	$2.65M	Buy	12,195 +1,064	+10%	+$236K	0.6%	31
2025 Q4	$2.54M	Buy	11,131 +1,220	+12%	+$278K	0.76%	31
2025 Q3	$2.29M	Hold	9,911	–	–	0.73%	31
2025 Q2	$1.84M	Buy	9,911 +6,254	+171%	+$1.16M	0.65%	36
2025 Q1	$766K	Buy	3,657 +784	+27%	+$152K	0.4%	66
2024 Q4	$511K	Buy	2,873 +123	+4%	+$22.6K	0.31%	67
2024 Q3	$543K	Hold	2,750	–	–	0.42%	56
2024 Q2	$472K	Hold	2,750	–	–	0.38%	59
2024 Q1	$501K	Hold	2,750	–	–	0.43%	56
2023 Q4	$426K	Buy	+2,750	New	+$401K	0.4%	58

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Cove Private Wealth's ABBV Position: Q2 2026 in Review

Cove Private Wealth increased its AbbVie (ABBV) stake by 1.3% in Q2 2026, buying an estimated $33.3K and bringing the position to 12,350 shares worth $3.11M. The position accounts for 0.6% of the portfolio, ranked #32.

Cove Private Wealth first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,017 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Cove Private Wealth held 12,350 shares of AbbVie worth $3.11M as of Q2 2026.
Cove Private Wealth bought 155 AbbVie shares in Q2 2026, an estimated $33.3K.
AbbVie made up 0.6% of Cove Private Wealth's portfolio in Q2 2026, its #32 holding.
Cove Private Wealth first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
2,017 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cove Private Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.